Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FVKSU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,331
Award facts
- Contract value 100% obligated
- $44,331.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,331.49 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This firm fixed-price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, was competitively awarded without set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies essential medications to military and veteran healthcare systems. The company's comprehensive IDC with DLA enables it to provide a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This specific delivery order for Ozempic, a diabetes medication, exemplifies the company's role in fulfilling federal healthcare pharmaceutical requirements through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FVKSU?
SPE2DB25FVKSU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FVKSU worth?
The government has obligated $44,331 on SPE2DB25FVKSU.
Is contract SPE2DB25FVKSU an order under another contract?
Yes. SPE2DB25FVKSU is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB25FVKSU competed?
The extent of competition for SPE2DB25FVKSU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award